Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II Chemotherapy with Caracemide in Patients with Unresectable or Recurrent non-Small Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to physiologic 70				NCI				UMCC-8532 NCI-T86-0005C, T86-0005


2.		Phase II Chemotherapy with Caracemide in Patients with Advanced or Recurrent Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				UMCC-8534 NCI-T86-0007C, T86-0007


3.		Phase II Master Protocol of New Agents in Patients with Advanced Unresectable non-Small Cell Bronchogenic Carcinoma --- Caracemide

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ICC-86L1 NCI-T86-0012D, T86-0012

Last Modified: 6/1/1990


4.		Phase II Study of Chemotherapy with Caracemide in Patients with Advanced Large Bowel Cancer (Summary Last Modified 06/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				EST-3287

Last Modified: 4/26/2007


5.		Phase II Randomized Evaluation of Single-Agent Chemotherapy with Amonafide or Caracemide in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 10/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				EST-3888

Last Modified: 6/1/1989


6.		Phase II Study of Caracemide in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 06/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NYMC-T88-0188 NCI-T88-0188O, T88-0188

Last Modified: 10/1/1989


7.		Phase II Study of Intravenous Caracemide in Patients with Advanced Breast Cancer (Summary Last Modified 10/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				NYMC-T89-0030 NCI-T89-0030O, T89-0030


8.		Phase I Evaluation of Caracemide

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 15				NCI				MDA-DM-8330 NCI-T83-0862W, T83-0862


9.		Phase I Chemotherapy with Caracemide in Adult Patients with Carcinomas, Sarcomas, or Lymphomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 18				NCI				WSU-A-52683 NCI-T84-0243W, T84-0243


10.		Phase I Chemotherapy with Intermittent Bolus Injections of Caracemide for Refractory Adult Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 18				NCI				PCCC-84154 NCI-T84-0316W, T84-0316

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute